TY - JOUR
T1 - Exploring the mechanistic insights of Cas scaffolding protein family member 4 with protein tyrosine kinase 2 in Alzheimer’s disease by evaluating protein interactions through molecular docking and dynamic simulations
AU - Hassan, Mubashir
AU - Shahzadi, Saba
AU - Alashwal, Hany
AU - Zaki, Nazar
AU - Seo, Sung Yum
AU - Moustafa, Ahmed A.
PY - 2018/5/22
Y1 - 2018/5/22
N2 - Cas scaffolding protein family member 4 and protein tyrosine kinase 2 are signaling proteins, which are involved in neuritic plaques burden, neurofibrillary tangles, and disruption of synaptic connections in Alzheimer’s disease. In the current study, a computational approach was employed to explore the active binding sites of Cas scaffolding protein family member 4 and protein tyrosine kinase 2 proteins and their significant role in the activation of downstream signaling pathways. Sequential and structural analyses were performed on Cas scaffolding protein family member 4 and protein tyrosine kinase 2 to identify their core active binding sites. Molecular docking servers were used to predict the common interacting residues in both Cas scaffolding protein family member 4 and protein tyrosine kinase 2 and their involvement in Alzheimer’s disease-mediated pathways. Furthermore, the results from molecular dynamic simulation experiment show the stability of targeted proteins. In addition, the generated root mean square deviations and fluctuations, solvent-accessible surface area, and gyration graphs also depict their backbone stability and compactness, respectively. A better understanding of CAS and their interconnected protein signaling cascade may help provide a treatment for Alzheimer’s disease. Further, Cas scaffolding protein family member 4 could be used as a novel target for the treatment of Alzheimer’s disease by inhibiting the protein tyrosine kinase 2 pathway.
AB - Cas scaffolding protein family member 4 and protein tyrosine kinase 2 are signaling proteins, which are involved in neuritic plaques burden, neurofibrillary tangles, and disruption of synaptic connections in Alzheimer’s disease. In the current study, a computational approach was employed to explore the active binding sites of Cas scaffolding protein family member 4 and protein tyrosine kinase 2 proteins and their significant role in the activation of downstream signaling pathways. Sequential and structural analyses were performed on Cas scaffolding protein family member 4 and protein tyrosine kinase 2 to identify their core active binding sites. Molecular docking servers were used to predict the common interacting residues in both Cas scaffolding protein family member 4 and protein tyrosine kinase 2 and their involvement in Alzheimer’s disease-mediated pathways. Furthermore, the results from molecular dynamic simulation experiment show the stability of targeted proteins. In addition, the generated root mean square deviations and fluctuations, solvent-accessible surface area, and gyration graphs also depict their backbone stability and compactness, respectively. A better understanding of CAS and their interconnected protein signaling cascade may help provide a treatment for Alzheimer’s disease. Further, Cas scaffolding protein family member 4 could be used as a novel target for the treatment of Alzheimer’s disease by inhibiting the protein tyrosine kinase 2 pathway.
UR - http://www.scopus.com/inward/record.url?scp=85052687981&partnerID=8YFLogxK
U2 - 10.1007/s10072-018-3430-2
DO - 10.1007/s10072-018-3430-2
M3 - Article
C2 - 29789968
AN - SCOPUS:85052687981
SN - 1590-1874
VL - 39
SP - 1361
EP - 1374
JO - Neurological Sciences
JF - Neurological Sciences
IS - 8
ER -